Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens

Tissue Antigens

Volumn 74, Issue 2, 2009, Pages 134-146

  Marrari, M ^a   Duquesnoy, R J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Epitope; Eplet; HLAMatchmaker; Human leukocyte antigen antibody; Human leukocyte antigen DR, DQ

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALGORITHM; AMINO ACID SEQUENCE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CORRELATION ANALYSIS; EPITOPE MAPPING; HLA MATCHING; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOREACTIVITY; PRIORITY JOURNAL;

ALGORITHMS; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; EPITOPE MAPPING; EPITOPES; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; MODELS, MOLECULAR; SEQUENCE ANALYSIS, PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67650462347     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01272.x     Document Type: Article

References (25)

1. Takemoto S, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004 : 4 : 1033 41.
2. Gebel H, Bray R, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 2003 : 3 : 1488 500.
3. Susal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002 : 73 : 1269 73.
4. Pollinger HS, Stegall MD, Gloor JM et al. Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant 2007 : 7 : 857 63.
5. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003 : 3 : 665 73.
6. Duquesnoy R, Awadalla Y, Lomago J et al. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes. Transpl Immunol 2008 : 18 : 352 60.
7. Deng CT, Cai J, Tarsitani C, El-Awar N, Lachmann N, Ozawa M. HLA class II DQ epitopes. Clin Transpl 2006 : 115 22.
8. Deng CT, El-Awar N, Ozawa M et al. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients. Transplantation 2008 : 86 : 452 9.
9. El-Awar N, Terasaki PI, Cai J et al. Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. Clin Transpl 2007 : 175 94.
10. Cai J, Terasaki PI, Mao Q et al. Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am J Transplant 2006 : 6 : 2947 54.
11. Cai J, Kohanof S, Terasaki P. HLA-DR Antibody Epitopes. Clin Transpl 2006 : 103 14.
12. Cai J, Terasaki P. Post-transplantation antibody monitoring and HLA antibody epitope identification. Curr Opin Immunol 2008 : 20 : 602 6.
13. Duquesnoy R. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr Opin Immunol 2008 : 20 : 594 601.
14. Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination V. Eplet matching for HLA-DR, HLA-DQ and HLA-DP. Hum Immunol 2007 : 68 : 12 25. (Pubitemid 46026884)
15. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006 : 67 : 847 62.
16. Duquesnoy R, Marrari M. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens 2009 : Submitted.
17. Hogue C. Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 1997 : 22 : 314 6.
18. Marsh SG, Bodmer JG. HLA-DR and -DQ epitopes and monoclonal antibody specificity. Immunol Today 1989 : 10 : 305 12.
19. Klohe E, Fu XT, Ballas M, Karr RW. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes. Hum Immunol 1993 : 37 : 51 8.
20. Drover S, Marshall WH, Kwok WW, Nepom GT, Karr RW. Amino acids in the peptide-binding groove influence an antibody-defined, disease-associated HLA-DR epitope. Scand J Immunol 1994 : 39 : 539 50.
21. Fu X-T, Drover S, Marshall WH, Karr RW. HLA-DR residues accessible under the peptide-binding groove contribute to polymorphic antibody epitopes. Hum Immunol 1995 : 43 : 243 50.
22. Smith KD, Mace BE, Valenzuela A et al. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. J Immunol 1996 : 157 : 2470 8.
23. Marrari M, Duquesnoy R. Why can sensitization by a HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1? Hum Immunol 2009 (in press).
24. Duquesnoy RJ, Mulder A, Askar M, Fernandez-Vina M, Claas FHJ. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005 : 66 : 749 61.
25. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. ASHI Quarterly 2002 : 60 2.